co.don AG supports international congress for cartilage reconstruction surgery
(Thomson Reuters ONE) -
co.don AG /
co.don AG supports international congress for cartilage reconstruction surgery
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
International Cartilage Repair Society (ICRS) convened for the first time in
Germany
More than 100 internationally renowned surgeons and researchers met from 25-27
August 2011 at the Rostock University Anatomical Institute. During the three-day
practical course organised by the ICRS the latest therapeutic advances were
demonstrated in lectures, live operations and workshops chaired by international
specialists.
"We have tried to give an objective representation of the full breadth of
cartilage reconstruction surgery, based on the state of current academic
research, and to illustrate it with the best surgeons and researchers in the
corresponding fields", explained course director PD Dr. med. habil. Peter
Cornelius Kreuz, senior consultant at the orthopaedic university clinic in
Rostock. "At the congress this entailed presentations of the most diverse range
of biological therapies for patients young and old suffering from cartilage
damage. They included demonstrations of stem cell-based methods, osteochondral
therapies, autologous cartilage reconstruction procedures and biomaterials but
also of very different biomechanical corrective operations such as osteotomies
and soft-tissue balancing for a homogeneous distribution of pressure and weight
in the knee joint", added PD Dr. Kreuz.
The autologous chondrocyte transplantations (ACT) also featured the cartilage
cell products from co.don AG. co.don AG is a partner of the congress and has
been carrying out research since the 1990s into regenerative biotechnology aimed
at the preservation of the joint. More than 4,000 patients have already been
treated with the patented co.don procedure. "It was a natural choice for us to
support the leading international joint specialists in carrying out these
practical courses", commented Dr. Baltrusch, CEO of co.don AG. "We are delighted
that his high-calibre association has met for the first time in this form in
Germany and that we had the opportunity to convince even more physicians of our
gentle and effective ACT-3D method."
The International Cartilage Repair Society was established at the end of the
1990s in Switzerland with the aim of fostering a worldwide exchange between
scientists and doctors. The participants at this year's congress included Prof.
Lars Peterson, who some 20 years ago was the first person to implant cultivated
cartilage cells into a human knee. The cartilage cell transplantation enables
the regenerative treatment of defective articular cartilage in knee, hip, ankle,
elbow and shoulder joints. The objective is to preserve the joint and therefore
to postpone or avert the use of a prosthesis altogether.
The International Cartilage Repair Society provides a forum for experts from all
over the world to network. They are pioneers and innovators in the field of
regenerative and personalised medicine. "Focused research is needed to develop
therapeutic concepts for different types of cartilage damage, which given the
appropriate biological and biomechanical parameters of the joints can prevent
arthritis", explains PD Dr. Kreuz.
About co.don(®) AG:
The company is based in Teltow, Brandenburg, and was founded in 1993. Since
2001 the bio-pharmaceutical specialist has been listed on the Frankfurt Stock
Exchange (ISIN: DE000A1K0227). co.don AG uses tissue engineering - the
cultivation and growth of autologous tissue cells - to develop innovative
products and therapeutic concepts for the orthopaedic and neurosurgical markets.
The cell-based biological drugs (autologous cell transplants for articular
cartilage and intervertebral disks) are produced without the use of antibiotics,
growth factors and genetic engineering. The Management Board of co.don(®) AG is
made up of Dr Andreas Baltrusch (CEO) and Ms Vilma Siodla (COO).
Further information is available from: www.codon.de
Press contact
BrunoMedia Communication GmbH
Gerd J. Gauger
Bonner Straße 328
50968 Köln
Tel:+49 (0)221 -348 038 38 10
Fax:+49 (0)221 -348 038 38 41
Email:codon(at)brunomedia.de
--- End of Message ---
co.don AG
Warthestr. 21 Teltow Germany
WKN: 517360 ;ISIN: DE0005173603;Index:CDAX;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Niedersächsische Börse zu Hannover,
General Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
Press release (PDF):
http://hugin.info/132731/R/1543026/472518.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: co.don AG via Thomson Reuters ONE
[HUG#1543026]
Unternehmensinformation / Kurzprofil:
Datum: 31.08.2011 - 16:40 Uhr
Sprache: Deutsch
News-ID 61241
Anzahl Zeichen: 5984
contact information:
Town:
Teltow
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 205 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"co.don AG supports international congress for cartilage reconstruction surgery"
steht unter der journalistisch-redaktionellen Verantwortung von
co.don AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
